-
-
Anti-ANGPTL3 Reference Antibody (evinacumab),, 50 микрограмм
-
Anti-ANGPTL4 Reference Antibody (Nanyang Tech.U. patent anti-ANGPTL4),, 50 микрограмм
-
Anti-ANGPT2 Reference Antibody (zansecimab),, 50 микрограмм
-
Anti-ANGPT2 Reference Antibody (nesvacumab),, 50 микрограмм
-
Anti-ANGPT2 Reference Antibody (Roche patent anti-ANG-2),, 50 микрограмм
-
Anti-ANGPT2 Reference Antibody (MEDI3617),, 50 микрограмм
-
Anti-Amyloid Beta Reference Antibody (U.Illinois scFv59),, 50 микрограмм
-
Anti-Amyloid Beta Reference Antibody (U.Zurich patent anti-Amyloid Beta),, 50 микрограмм
-
Anti-Amyloid Beta Reference Antibody (solanezumab),, 50 микрограмм
-
Anti-Amyloid Beta Reference Antibody (ponezumab),, 50 микрограмм
-
Anti-Amyloid Beta Reference Antibody (Rockefeller U. patent anti-Amyloid Beta),, 50 микрограмм
стр.: